Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-24-005052
Filing Date
2024-11-14
Accepted
2024-11-14 15:05:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 cormorant-tcrx093024a1.htm SC 13G/A 85961
  Complete submission text file 0001172661-24-005052.txt   87645
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

EIN.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Subject) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92700 | Film No.: 241460762
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)